Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EVEROLIMUS vs EXEMESTANE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EVEROLIMUS vs EXEMESTANE: Safety Overview

Metric EVEROLIMUS EXEMESTANE
Total FAERS Reports 39,640 10,418
Deaths Reported 8,374 1,256
Death Rate 21.1% 12.1%
Hospitalizations 11,211 2,327
Average Patient Age 53.4 yrs 64.2 yrs
% Female Patients 60.0% 98.7%
FDA Approval Date Apr 12, 2018 Apr 1, 2011
Manufacturer Amneal Pharmaceuticals NY LLC Zydus Lifesciences Limited
Route ORAL ORAL
Marketing Status Prescription Prescription